TREND statement checklist.

<div><p>Background</p><p>Postoperative nausea and vomiting are common complications after surgery, and female patients are more likely to experience these adverse events. The goal of this study was to explore the relationship between the <i>CHRM3 rs2165870</i> polymorphism and postoperative vomiting incidence in female patients who underwent laparoscopic surgery.</p><p>Methods</p><p>Two hundred female patients who underwent elective laparoscopic surgery with subsequent patient-controlled intravenous analgesia using dexmedetomidine and sufentanil were prospectively enrolled. The <i>CHRM3 rs2165870</i> and <i>KCNB2 rs349358</i> polymorphisms were genotyped using MassARRAY SNP typing technology. Demographic data and preoperative laboratory results of all patients were recorded. Postoperative analgesia-related information, incidence of postoperative nausea and vomiting, and other adverse events were followed up and recorded for analysis.</p><p>Results</p><p>No significant differences were observed in any of the demographic characteristics of these patients among the different genotype carriers (<i>P</i>>0.05). The percentages of patients with each genotype of <i>CHRM3</i> were 67% (GG), 28.5% (GA) and 4.5% (AA). We found that the AA or A allele of the <i>CHRM3 rs2165870</i> polymorphism elevated the risk of postoperative vomiting (AA versus GG; OR, 6.94; 95% CI, 1.49–32.46; <i>P</i> = 0.014; A versus G; OR, 2.52; 95% CI, 1.22–5.19; <i>P</i> = 0.012). The percentages of patients with each genotype of <i>KCNB2</i> were 84.5% (TT), 15.5% (CT) and 0% (CC). There were no significant differences in the postoperative nausea or vomiting rate across the <i>KCNB2 rs349358</i> polymorphisms (<i>P</i>>0.05).</p><p>Conclusion</p><p>The <i>CHRM3 rs2165870</i> polymorphism is associated with the occurrence of postoperative vomiting in female patients who have undergone laparoscopic surgery. The AA genotype or A allele of the <i>CHRM3 rs2165870</i> polymorphism elevates the risk of postoperative vomiting.</p><p>Trial registration</p><p><a href="http://www.chictr.org.cn/" target="_blank">www.chictr.org.cn</a>, registration number: <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/ictrp-ChiCTR2200062425" target="_blank">ChiCTR2200062425</a>.</p></div>

Publication Details

Journal
Figshare
Published
2024-08-20
DOI
https://doi.org/10.1371/journal.pone.0309136.s002
Primary Topic
Nausea and vomiting management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TREND statement checklist.

Figshare
Nausea and vomiting management
article

TREND statement checklist.

article en

Abstract

<div><p>Background</p><p>Postoperative nausea and vomiting are common complications after surgery, and female patients are more likely to experience these adverse events. The goal of this study was to explore the relationship between the <i>CHRM3 rs2165870</i> polymorphism and postoperative vomiting incidence in female patients who underwent laparoscopic surgery.</p><p>Methods</p><p>Two hundred female patients who underwent elective laparoscopic surgery with subsequent patient-controlled intravenous analgesia using dexmedetomidine and sufentanil were prospectively enrolled. The <i>CHRM3 rs2165870</i> and <i>KCNB2 rs349358</i> polymorphisms were genotyped using MassARRAY SNP typing technology. Demographic data and preoperative laboratory results of all patients were recorded. Postoperative analgesia-related information, incidence of postoperative nausea and vomiting, and other adverse events were followed up and recorded for analysis.</p><p>Results</p><p>No significant differences were observed in any of the demographic characteristics of these patients among the different genotype carriers (<i>P</i>>0.05). The percentages of patients with each genotype of <i>CHRM3</i> were 67% (GG), 28.5% (GA) and 4.5% (AA). We found that the AA or A allele of the <i>CHRM3 rs2165870</i> polymorphism elevated the risk of postoperative vomiting (AA versus GG; OR, 6.94; 95% CI, 1.49–32.46; <i>P</i> = 0.014; A versus G; OR, 2.52; 95% CI, 1.22–5.19; <i>P</i> = 0.012). The percentages of patients with each genotype of <i>KCNB2</i> were 84.5% (TT), 15.5% (CT) and 0% (CC). There were no significant differences in the postoperative nausea or vomiting rate across the <i>KCNB2 rs349358</i> polymorphisms (<i>P</i>>0.05).</p><p>Conclusion</p><p>The <i>CHRM3 rs2165870</i> polymorphism is associated with the occurrence of postoperative vomiting in female patients who have undergone laparoscopic surgery. The AA genotype or A allele of the <i>CHRM3 rs2165870</i> polymorphism elevates the risk of postoperative vomiting.</p><p>Trial registration</p><p><a href="http://www.chictr.org.cn/" target="_blank">www.chictr.org.cn</a>, registration number: <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/ictrp-ChiCTR2200062425" target="_blank">ChiCTR2200062425</a>.</p></div>

Figshare
Good health and well-being
Openalex Percentile: Top 49%
Nausea and vomiting management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.